XML 22 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Changes in Stockholders' Deficit and Non-Controlling Interests - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Deficit Attributable to Stockholders
NCIs
Beginning balance (in shares) at Dec. 31, 2018   67,038 0        
Beginning balance at Dec. 31, 2018 $ (94,018) $ 67 $ 0 $ 0 $ (94,085) $ (94,018) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-classified stock-based compensation 3,652     3,652   3,652  
Vesting of stock-based compensation (in shares)   54          
Vesting of stock-based compensation   $ 1   (1)      
Warrant redemptions (in shares)   420          
Stock repurchases (in shares)   (451) 451        
Share repurchases 2,388   $ 2,388     2,388  
Net (loss) income attributable to common stockholders (33,589)       (33,589) (33,589)  
Issuance of NCI in subsidiary 5,654           5,654
Net income (loss) (33,589)            
Ending balance (in shares) at Dec. 31, 2019   67,061 451        
Ending balance at Dec. 31, 2019 (120,689) $ 68 $ (2,388) 3,651 (127,674) (126,343) 5,654
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-classified stock-based compensation 2,118     2,118   2,118  
Vesting of stock-based compensation (in shares)   330          
Redemption of NCI in subsidiary (5,654)           (5,654)
Earnings attributable to redeemable and redeemed NCIs 45,398           45,398
Earnings distributed to redeemable and redeemed NCIs (45,398)           (45,398)
Net (loss) income attributable to common stockholders 25,661       25,661 25,661  
Net income (loss) 71,059            
Ending balance (in shares) at Dec. 31, 2020   67,391 451        
Ending balance at Dec. 31, 2020 (98,564) $ 68 $ (2,388) 5,769 (102,013) (98,564) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Equity-classified stock-based compensation 2,888     2,888   2,888  
Vesting of stock-based compensation (in shares)   465          
Liability-classified stock-based compensation converted to equity-classified 313     313   313  
Issuance of common stock (in shares)   7,551          
Issuance of common stock 34,388 $ 7   34,381   34,388  
Exercise of stock options 1,195 $ 174   1,195   1,195  
Fair value of NCI preferred units redemption, net of deferred tax benefit (8,021)     (8,021)   (8,021)  
Fair value of common shares issued for NCI redemption (in shares)   1,428          
Fair value of common shares issued for NCI redemption 9,964 $ 2   9,962   9,964  
Stock repurchases (in shares)   (269) 269        
Share repurchases 1,703   $ 1,703     1,703  
Warrants issued 11,357     11,357   11,357  
Dividends on redeemable senior preferred stock 16,164     16,164   16,164  
Accretion of redeemable senior preferred stock 1,845     1,845   1,845  
Change in estimate of tax basis differences 566       566 566  
Net income (loss) 1,389       1,389 1,389  
Ending balance (in shares) at Dec. 31, 2021   76,740 720        
Ending balance at Dec. 31, 2021 $ (64,237) $ 77 $ (4,091) $ 39,835 $ (100,058) $ (64,237) $ 0